Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatmentCaterina E Faliti, Fabliha A Anam, Narayanaiah Cheedarla, et al.
Science (New York, N.Y.)|April 26, 2024
Developing transmissible vaccines for animal infectionsDaniel G Streicker, Megan E Griffiths, Rustom Antia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2022
Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic LeukemiaAndres Chang, Akil Akhtar, Susanne L Linderman, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2020
Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humansAli H Ellebedy, Raffael Nachbagauer, Katherine J L Jackson, et al.
Nature Immunology|November 12, 2024
Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLECaterina E Faliti, Trinh T P Van, Fabliha A Anam, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2021
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cellsKristen W Cohen, Susanne L Linderman, Zoe Moodie, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concernRajesh Valanparambil, Jennifer Carlisle, Susanne Linderman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron VariantRajesh M Valanparambil, Jennifer Carlisle, Susanne L Linderman, et al.
Pageof 12